TITLE

The dual role of Candida glabrata Drug:H+ Antiporter CgAqr1 (ORFCAGL0J09944g) in antifungal drug and acetic acid resistance

AUTHOR(S)
Costa, Catarina; Henriques, André; Pires, Carla; Nunes, Joana; Ohno, Michiyo; Chibana, Hiroji; Sá-Correia, Isabel; Teixeira, Miguel C.
PUB. DATE
June 2013
SOURCE
Frontiers in Microbiology;Jun2013, Vol. 4, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
88067115

 

Related Articles

  • MFS multidrug transporters in pathogenic fungi: do they have real clinical impact? Costa, Catarina; Dias, Paulo J.; Sá-Correia, Isabel; Teixeira, Miguel C. // Frontiers in Physiology;May2014, Vol. 5, p1 

    Infections caused by opportunistic fungal pathogens have reached concerning numbers due to the increase of the immunocrompromised human population and to the development of antifungal resistance. This resistance is often attributed to the action of multidrug efflux pumps, belonging to the...

  • Candida glabrata drug:H+ antiporter CgTpo3 (ORF CAGL0I10384g): role in azole drug resistance and polyamine homeostasis. Costa, Catarina; Nunes, Joana; Henriques, André; Mira, Nuno P.; Nakayama, Hironobu; Chibana, Hiroji; Teixeira, Miguel C. // Journal of Antimicrobial Chemotherapy (JAC);Jul2014, Vol. 69 Issue 7, p1767 

    Objectives The ability of opportunistic pathogenic Candida species to persist and invade specific niches in the human host depends on their resistance to natural growth inhibitors and antifungal therapy. This work describes the role of the Candida glabrata drug:H+ antiporter CgTpo3 (ORF...

  • Candida glabrata Endophthalmitis Treated Successfully with Caspofungin. Sarria, Juan C.; Bradley, Jay C.; Habash, Ranya; Mitchell, Kelly T.; Kimbrough, Robert C.; Vidal, Ana M. // Clinical Infectious Diseases;3/1/2005, Vol. 40 Issue 5, pe46 

    A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of...

  • Regulation of multidrug resistance in pathogenic fungi.  // Journal of Invasive Fungal Infections;2010, Vol. 3 Issue 4, p139 

    In this article, the author summarizes the current knowledge on drug transporters, efflux pumps, and major facilitator superfamilies and their roles in drug resistance in opportunistic pathogenic fungi. These mechanisms of antifungal drug resistance have been identified and described in the...

  • 真菌多药耐药外排机制的研究进展. 康烨; 周密; 阎澜 // Journal of Pharmaceutical Practice;Nov2016, Vol. 34 Issue 6, p485 

    The multidrug resistance (MDR), characterized by the simultaneous acquisition of resistance to chemically and structurally different drugs, has caused antifungal treatment failure. This review focused on recent progresses in understanding of the multidrug resisitance associated drug efflux...

  • Emergence of multiple resistance profiles involving azoles, echinocandins and amphotericin B in Candida glabrata isolates from a neutropenia patient with prolonged fungaemia. Eun-Jung Cho; Jong Hee Shin; Soo Hyun Kim; Hyun-Ki Kim; Jeong Su Park; Heungsup Sung; Mi-Na Kim; Ho Joon Im // Journal of Antimicrobial Chemotherapy (JAC);Apr2015, Vol. 70 Issue 4, p1268 

    The article describes the case of a male patient with prolonged fungaemia who developed multiple resistance to Candida glabrata. Particular focus is given to the patient's medical history, as well as treatment regimens. Topics discussed include antifungal susceptibility testing of clinical...

  • Determination of Antifungal Susceptibility Patterns Among the Clinical Isolates of Candida Species. Zomorodian, Kamiar; Rahimi, Mohammad Javad; Pakshir, Kayvan; Motamedi, Marjan; Ghiasi, Moosa Rahimi; Rezashah, Hasanein // Journal of Global Infectious Diseases;Oct2011, Vol. 3 Issue 4, p357 

    Context: Candida species are opportunistic yeasts that cause infections ranging from simple dermatosis to potentially lifethreatening fungemia. The emergence of resistance to antifungal drugs has been increased in the past two decades. Aim: the present study we determined to find out the...

  • Drug resistance: The fight against fungi. Goffeau, André // Nature;4/3/2008, Vol. 452 Issue 7187, p541 

    The article reflects on the findings of a study that focused on the molecular mechanism behind antifungal-drug resistance. According to the author, the researchers found out that several xenobiotics and antifungal agents can bind directly to a hydrophobic domain (XBD) of Saccharomyces (S.)...

  • The effect of biomaterials and antifungals on biofilm formation by Candida species: a review. Cuéllar-Cruz, M.; Vega-González, A.; Mendoza-Novelo, B.; López-Romero, E.; Ruiz-Baca, E.; Quintanar-Escorza, M.; Villagómez-Castro, J. // European Journal of Clinical Microbiology & Infectious Diseases;Oct2012, Vol. 31 Issue 10, p2513 

    Candida albicans, C. glabrata, C. parapsilosis, and C. tropicalis are able to form biofilms on virtually any biomaterial implanted in a human host. Biofilms are a primary cause of mortality in immunocompromised and hospitalized patients, as they cause recurrent and invasive candidiasis, which is...

  • Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection. Schelenz, Silke; Ross, Calum N. // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p1 

    Background: Caspofungin is a new antifungal agent with high-level activity against a number of Candida species including those that are resistant to azoles. Its good safety profile and low nephrotoxicity makes it an attractive drug to treat fungal infections in patients with compromised renal...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics